Sansert is a brand name for methysergide, a member of the ergoline group. Methysergide is one of the most effective medications for prevention, but not treatment, of migraine headaches. However, it has a known side-effect, retroperitoneal fibrosis, that is severe, although uncommon. Novartis appears to have withdrawn it from the U.S. market after taking over Sandoz.